Evidence map›Paper›PMID 40525124›Full record

ArticleMolecular therapy. Methods & clinical development2025

Exploring the potential of saponins as adjuvants in lipid-nanoparticle-based mRNA vaccines.

Yulia Eygeris, Antony Jozic, Michael I Henderson, Dylan Nelson, Gaurav Sahay

Abstract read
In one paragraph

Article in Molecular therapy. Methods & clinical development, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Bioactive lipid-derived nanoparticles for RNA delivery.Materials today (Kidlington, England) · 2026
    Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Yulia EygerisDepartment of Pharmaceutical Sciences, College of Pharmacy, Oregon State University, Portland OR 97201, USA.
Antony JozicDepartment of Pharmaceutical Sciences, College of Pharmacy, Oregon State University, Portland OR 97201, USA.
Michael I HendersonDepartment of Pharmaceutical Sciences, College of Pharmacy, Oregon State University, Portland OR 97201, USA.
Dylan NelsonDepartment of Pharmaceutical Sciences, College of Pharmacy, Oregon State University, Portland OR 97201, USA.
Gaurav SahayDepartment of Pharmaceutical Sciences, College of Pharmacy, Oregon State University, Portland OR 97201, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Saponins are a class of phytocompounds known for their amphiphilic properties. Here, we have evaluated incorporation of 40 saponins into a model lipid nanoparticle (LNP) formulation and evaluated their performance

Indexed as

adjuvantgene therapylipid nanoparticlemRNA deliverysaponinsstructure-activity relationshipsvaccine

Identifiers

PMID40525124
PMCPMC12169741

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.